- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Immobilier
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 224 results
Webinar
septembre 30, 2021
Emerging Trends Regarding EPA’s Regulations Affecting Products: What Life Sciences Companies Should Know
Webinar
septembre 28, 2021
USMCA – Lessons Learned After the First Year: Origin, Labor, Autos, & Energy
Webinar
septembre 22, 2021
Key Food and Beverage Issues – Social and Environmental Responsibility in Manufacture, Supply and Advertising
Webinar
septembre 20, 2021
30th Annual Health Law & Policy Forum
Webinar
septembre 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
août 26, 2021
Post-Acute Care False Claims Act Trends
Webinar
juillet 28, 2021
COVID-Related Litigation and the PREP Act: A Year Later
Webinar
juillet 20, 2021
What Providers Need to Know about the No Surprises Act Interim Final Rules Issued on July 1, 2021
Webinar
juin 22, 2021
Ransomware Attacks and Force Majeure(?)
Webinar
juin 16, 2021
8th Annual Cybersecurity & Privacy Summit
Webinar
juin 15, 2021
Real-World Evidence: The Evolving Landscape for FDA and EU Decision-Making About Drugs, Biologics, and Medical Devices
Webinar
juin 9, 2021
Managing Workforce Diversity, Equity & Inclusion in Technology